Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Sleep Cycle

15,36 SEK

-1,16 %

Mindre end 1K følgere

SLEEP

NASDAQ Stockholm

Software

Technology

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-1,16 %
-41,49 %
-40,12 %
-29,22 %
-46,29 %
-65,79 %
-63,99 %
-
-80,75 %

Sleep Cycle operates in the technology industry and focuses on the development and distribution of a mobile app for search analysis and wake-up. The company's products are aimed at individuals who want to improve their sleep quality and well-being. The business is global with a primary presence in Europe, North America and Asia. Sleep Cycle was founded in 2001 and is headquartered in Göteborg, Sweden.

Læs mere
Markedsværdi
311,46 mio. SEK
Aktieomsætning
534,99 t SEK
Omsætning
247,88 mio.
EBIT %
26,61 %
P/E
5,86
Udbytteafkast, %
3,45 %
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
13.4
2026

Generalforsamling '26

14.4
2026

Årligt udbytte

29.4
2026

Delårsrapport Q1'26

Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsei går

Sleep Cycle and Carnegie Mellon To Explore Sleep Data To Detect Outbreaks

Sleep Cycle
Pressemeddelelse5.2.2026, 09.53

Redeye: Sleep Cycle (Q4 Review): 2026 – a year of investments for future growth

Sleep Cycle
Pressemeddelelse5.2.2026, 06.53

DNB Carnegie Access: Sleep Cycle: Focus on long-term investments in 2026 – Q4 review

Sleep Cycle

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Sleep Cycle, Audiocast, Q4'25
Videopræsentation4.2.2026, 08.30

Sleep Cycle, Audiocast, Q4'25

Sleep Cycle
Pressemeddelelse4.2.2026, 08.18

DNB Carnegie Access: Sleep Cycle: Guidance lower than our estimates – Q4 initial take

Sleep Cycle
Selskabsmeddelelse4.2.2026, 06.30

Sleep Cycle Year-end report: A year of deliberate choices

Sleep Cycle
Pressemeddelelse28.1.2026, 11.30

UKHSA and Sleep Cycle: Could sleep app data help identify respiratory disease trends in England?

Sleep Cycle
Pressemeddelelse23.1.2026, 08.49

DNB Carnegie Access: Sleep Cycle: Initiates clinical validation for AI sleep apnoea screening tool

Sleep Cycle
Selskabsmeddelelse23.1.2026, 07.00

Sleep Cycle initiates US-based clinical validation for AI sleep apnea screening tool

Sleep Cycle
Pressemeddelelse21.1.2026, 07.00

Sleep Cycle AB (publ) invites you to a presentation of its year-end report for 2025

Sleep Cycle
Pressemeddelelse9.1.2026, 08.06

DNB Carnegie Access: Sleep Cycle: Focus should be on partner revenue – Q4 preview

Sleep Cycle
Pressemeddelelse18.12.2025, 09.12

DNB Carnegie Access: Sleep Cycle: Signs licencing agreement with global IoT company

Sleep Cycle
Pressemeddelelse18.12.2025, 08.00

Sleep Cycle signs multi-year SDK licensing agreement with global IoT company

Sleep Cycle
Pressemeddelelse3.12.2025, 14.22

DNB Carnegie Access: Sleep Cycle: Launches new features

Sleep Cycle
Pressemeddelelse3.12.2025, 12.00

Sleep Cycle Launches Luma, a Life-Improving AI Backed by Science

Sleep Cycle
Pressemeddelelse20.11.2025, 08.00

Rested Minds, Active Bodies: A New Partnership Between Sleep Cycle and Urban Sports Club

Sleep Cycle
Selskabsmeddelelse28.10.2025, 08.00

Resolutions at Sleep Cycle’s Extraordinary General Meeting 2025

Sleep Cycle
Pressemeddelelse27.10.2025, 13.23

Redeye: Sleep Cycle (Q3 Review) - Resilient profitability and diversification progress at trough valuation

Sleep Cycle
Pressemeddelelse27.10.2025, 11.10

DNB Carnegie Access: Sleep Cycle: Launches first pilot for Sleep SDK

Sleep Cycle
Pressemeddelelse27.10.2025, 09.15

Sleep Cycle launches pilot with Ultrahuman – a key milestone in the company’s licensing strategy

Sleep Cycle
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.